"The Buzz" Show: Auris Medical (NASDAQ: EARS) Provides Update on Bentrio Program in Allergy | Financial Buzz"The Buzz" Show: Auris Medical (NASDAQ: EARS) Provides Update on Bentrio Program in Allergy
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Auris Medical Provides Update on Bentrio Program in Allergy” Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders, and its affiliate Altamira Medica Ltd. today announced additional details on the outcomes from the clinical investigation of its BentrioTM nasal spray in allergic rhinitis and provided an update on the regulatory pathway in the US for the intend...
Source: financialbuzz.com